Mono Pharmacare IPO vs Pramara Promotions IPO

Comparison between Mono Pharmacare IPO and Pramara Promotions IPO.

IPO Details

Mono Pharmacare IPO is a SME Fixed Price IPO proposed to list at NSE SME while Pramara Promotions IPO is a SME Fixed Price proposed to list at NSE SME.

Issue Size and Price

The total issue size of Mono Pharmacare IPO is up to ₹14.07 Cr whereas the issue size of the Pramara Promotions IPO is up to ₹14.49 Cr. The final issue price of Mono Pharmacare IPO is ₹28.00 per share and of Pramara Promotions IPO is ₹63.00 per share.

 Mono Pharmacare IPOPramara Promotions IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹26.00 per share
Issue Price (Upper)₹28.00 per share
Issue Price (Final)₹28.00 per share₹63.00 per share
Discount (Retail)₹0.00 per share₹0.00 per share
Market Lot Size4000 shares2000 shares
Fresh Issue Size50,24,000 shares23,00,000 shares
Fresh Issue Size (Amount)up to ₹14.07 Crup to ₹14.49 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total50,24,000 shares23,00,000 shares
Issue Size Total (Amount)up to ₹14.07 Crup to ₹14.49 Cr

IPO Timetable

Mono Pharmacare IPO opens on Aug 28, 2023, while Pramara Promotions IPO opens on Sep 01, 2023. The closing date of Mono Pharmacare IPO and Pramara Promotions IPO is Aug 30, 2023, and Sep 05, 2023, respectively.

 Mono Pharmacare IPOPramara Promotions IPO
Issue OpenAug 28, 2023Sep 01, 2023
Issue CloseAug 30, 2023Sep 05, 2023
Basis Of Allotment (Tentative)Sep 04, 2023Sep 08, 2023
Initiation of Refunds (Tentative)Sep 05, 2023Sep 11, 2023
Credit of Share (Tentative)Sep 06, 2023Sep 12, 2023
Listing date (Tentative)Sep 07, 2023Sep 13, 2023

Financials & KPIs

Mono Pharmacare IPO P/E ratio is , as compared to Pramara Promotions IPO P/E ratio of .

 Mono Pharmacare IPOPramara Promotions IPO
Financials

Company Financials (Restated Consolidated)

Period Ended31 Mar 202331 Mar 202231 Mar 202131 Mar 2020
Assets62.5714.3811.228.72
Total Income37.1028.3811.69
Profit After Tax0.350.100.02
NET Worth4.283.702.02
Reserves and Surplus1.32
Total Borrowing6.446.086.33
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended31 Mar 202331 Mar 202231 Mar 2021
Assets61.3961.9549.23
Total Income51.1949.4340.96
Profit After Tax2.231.350.33
NET Worth15.9713.7412.35
Reserves and Surplus9.4412.5411.15
Total Borrowing33.3131.3430.33
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)81.02%95.41%
Promoter Shareholding (Post-Issue)56.72%69.81%
Market Cap₹49.47 Cr.₹56.92 Cr.
ROE9.0113.87
ROCE10.3415.20
Debt/Equity2.922.07
EPS₹1.99₹3.37
RoNW9.0113.87

Shares Offered

In the Mono Pharmacare IPO Retail Individual Investors (RII) are offered 22,64,000 shares while in Pramara Promotions IPO retail investors are offered 22,64,000 shares. Qualified Institutional Buyers (QIB) are offered 5,00,000 shares in Mono Pharmacare IPO and in Pramara Promotions IPO.

 Mono Pharmacare IPOPramara Promotions IPO
Market Maker Reservation2,76,000 shares1,24,000 shares
QIB5,00,000 shares
NII22,60,000 shares11,50,000 shares
RII22,64,000 shares11,50,000 shares
Total50,24,000 shares23,00,000 shares

Bids Received (Subscription)

Mono Pharmacare IPO subscribed 13.42x in total, whereas Pramara Promotions IPO subscribed 25.56x.

 Mono Pharmacare IPOPramara Promotions IPO
QIB (times)10.89x
NII (times)8.00x33.99x
RII (times)19.40x17.14x
Total (times)13.42x25.56x

Compare with others

Compare:

Mono Pharmacare IPO Vs Pramara Promotions IPO